{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T22:28:01Z","timestamp":1775600881007,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jpet.2025.103402","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:11:52Z","timestamp":1739405512000},"page":"103402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Predicting the effects of single pathological mutations in hemophilia A and type 2N von Willebrand diseases using AlphaFold2-multimer and AlphaFold3"],"prefix":"10.1016","volume":"392","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7142-0518","authenticated-orcid":false,"given":"Ziyu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6580-2464","authenticated-orcid":false,"given":"Heng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpet.2025.103402_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1-2","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"key":"10.1016\/j.jpet.2025.103402_bib2","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.jpet.2025.103402_bib3","first-page":"479","article-title":"Factor VIII replacement is still the standard of care in haemophilia A","volume":"17","author":"Aledort","year":"2019","journal-title":"Blood Transfus"},{"key":"10.1016\/j.jpet.2025.103402_bib4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-021-00278-x","article-title":"Haemophilia","volume":"7","author":"Berntorp","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jpet.2025.103402_bib5","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/humu.20403","article-title":"Spectrum of molecular defects and mutation detection rate in patients with mild and moderate hemophilia A","volume":"28","author":"Bogdanova","year":"2007","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jpet.2025.103402_bib6","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1055\/s-0037-1615134","article-title":"Type 2N von Willebrand disease: rapid genetic diagnosis of G2811A (R854Q), C2696T (R816W), T2701A (H817Q) and G2823T (C858F)\u2014detection of a novel candidate type 2N mutation: C2810T (R854W)","volume":"80","author":"Bowen","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jpet.2025.103402_bib7","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/s41467-022-28865-w","article-title":"Improved prediction of protein-protein interactions using AlphaFold2","volume":"13","author":"Bryant","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.jpet.2025.103402_bib8","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1182\/blood-2015-04-641688","article-title":"Mapping the interaction between factor VIII and von Willebrand factor by electron microscopy and mass spectrometry","volume":"126","author":"Chiu","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jpet.2025.103402_bib9","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1111\/jth.15817","article-title":"Characterization of interaction between blood coagulation factor VIII and LRP1 suggests dynamic binding by alternating complex contacts","volume":"20","author":"Chun","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jpet.2025.103402_bib10","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/humu.10119","article-title":"High throughput mutation screening of the factor VIII gene (F8C) in hemophilia A: 37 novel mutations and genotype-phenotype correlation","volume":"20","author":"Citron","year":"2002","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jpet.2025.103402_bib11","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1182\/blood-2018-10-876300","article-title":"The von Willebrand factor D'D3 assembly and structural principles for factor VIII binding and concatemer biogenesis","volume":"133","author":"Dong","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jpet.2025.103402_bib12","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1182\/blood.V91.7.2347","article-title":"A\u00a0human alloantibody interferes with binding of factor IXa to the factor VIII light chain","volume":"91","author":"Fijnvandraat","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jpet.2025.103402_bib13","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1182\/blood.2020009197","article-title":"Molecular determinants of the factor VIII\/von Willebrand factor complex revealed by BIVV001 cryo-electron microscopy","volume":"137","author":"Fuller","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jpet.2025.103402_bib14","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1038\/s41467-022-29394-2","article-title":"AF2Complex predicts direct physical interactions in multimeric proteins with deep learning","volume":"13","author":"Gao","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.jpet.2025.103402_bib15","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1365-2141.1991.tb04480.x","article-title":"Identification of two point mutations in the von Willebrand factor gene of three families with the 'Normandy' variant of von Willebrand disease","volume":"78","author":"Gaucher","year":"1991","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jpet.2025.103402_bib16","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1182\/blood-2006-05-020784","article-title":"Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD)","volume":"109","author":"Goodeve","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jpet.2025.103402_bib17","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1046\/j.1538-7836.2003.00149.x","article-title":"Thirty-four novel mutations detected in factor VIII gene by multiplex CSGE: modeling of 13 novel amino acid substitutions","volume":"1","author":"Habart","year":"2003","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jpet.2025.103402_bib18","doi-asserted-by":"crossref","first-page":"14505","DOI":"10.1074\/jbc.270.24.14505","article-title":"Residues 484-508 contain a major determinant of the inhibitory epitope in the A2 domain of human factor VIII","volume":"270","author":"Healey","year":"1995","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jpet.2025.103402_bib19","doi-asserted-by":"crossref","first-page":"7405","DOI":"10.1073\/pnas.88.16.7405","article-title":"Molecular characterization of severe hemophilia A suggests that about half the mutations are not within the coding regions and splice junctions of the factor VIII gene","volume":"88","author":"Higuchi","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jpet.2025.103402_bib20","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1160\/TH06-03-0157","article-title":"Type 2N von Willebrand disease due to compound heterozygosity for R854Q and a novel R763G mutation at the cleavage site of von Willebrand factor propeptide","volume":"96","author":"Hilbert","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jpet.2025.103402_bib21","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.3390\/molecules27041386","article-title":"Prediction of monomeric and dimeric structures of CYP102A1 using AlphaFold2 and AlphaFold multimer and assessment of point mutation effect on the efficiency of intra- and interprotein electron transfer","volume":"27","author":"Ivanov","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.jpet.2025.103402_bib22","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1046\/j.1365-2141.2001.02671.x","article-title":"Lithuanian haemophilia A and B registry comprising phenotypic and genotypic data","volume":"112","author":"Ivaskevicius","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jpet.2025.103402_bib23","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1182\/blood.V96.3.958","article-title":"A\u00a0novel cause of mild\/moderate hemophilia A: mutations scattered in the factor VIII C1 domain reduce factor VIII binding to von Willebrand factor","volume":"96","author":"Jacquemin","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jpet.2025.103402_bib24","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1182\/bloodadvances.2016002923","article-title":"Novel approach to genetic analysis and results in 3000 hemophilia patients enrolled in the My Life, Our Future initiative","volume":"1","author":"Johnsen","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.jpet.2025.103402_bib25","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jpet.2025.103402_bib26","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.3389\/fimmu.2019.02991","article-title":"Tolerating factor VIII: recent progress","volume":"10","author":"Lacroix-Desmazes","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jpet.2025.103402_bib27","doi-asserted-by":"crossref","first-page":"e331","DOI":"10.1111\/j.1365-2516.2011.02640.x","article-title":"Computational and molecular approaches for predicting unreported causal missense mutations in Belgian patients with haemophilia A","volume":"18","author":"Lannoy","year":"2012","journal-title":"Haemophilia"},{"key":"10.1016\/j.jpet.2025.103402_bib28","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1471-2350-9-53","article-title":"Mutation spectrum of 122 hemophilia A families from Taiwanese population by LD-PCR, DHPLC, multiplex PCR and evaluating the clinical application of HRM","volume":"9","author":"Lin","year":"2008","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.jpet.2025.103402_bib29","doi-asserted-by":"crossref","first-page":"722","DOI":"10.3324\/haematol.12427","article-title":"The Italian AICE-Genetics hemophilia A database: results and correlation with clinical phenotype","volume":"93","author":"Margaglione","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.jpet.2025.103402_bib30","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1365-2141.1990.tb06371.x","article-title":"Evidence for a von Willebrand factor defect in factor VIII binding in three members of a family previously misdiagnosed mild haemophilia A and haemophilia A carriers: consequences for therapy and genetic counselling","volume":"76","author":"Mazurier","year":"1990","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jpet.2025.103402_bib31","doi-asserted-by":"crossref","DOI":"10.1103\/PhysRevLett.131.218401","article-title":"AlphaFold2 can predict single-mutation effects","volume":"131","author":"McBride","year":"2023","journal-title":"Phys Rev Lett"},{"key":"10.1016\/j.jpet.2025.103402_bib32","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1055\/s-0037-1614329","article-title":"A\u00a0common splice site mutation is shared by two families with different type 2N von Willebrand disease mutations","volume":"82","author":"Nesbitt","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jpet.2025.103402_bib33","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2406407121","article-title":"AlphaFold-Multimer accurately captures interactions and dynamics of intrinsically disordered protein regions","volume":"121","author":"Omidi","year":"2024","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jpet.2025.103402_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0282689","article-title":"Using AlphaFold to predict the impact of single mutations on protein stability and function","volume":"18","author":"Pak","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.jpet.2025.103402_bib35","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1182\/blood-2016-04-713289","article-title":"Life in the shadow of a dominant partner: the FVIII-VWF association and its clinical implications for hemophilia A","volume":"128","author":"Pipe","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jpet.2025.103402_bib36","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1111\/j.1538-7836.2007.02591.x","article-title":"Factor VIII (FVIII) gene mutations in 120 patients with hemophilia A: detection of 26 novel mutations and correlation with FVIII inhibitor development","volume":"5","author":"Repesse","year":"2007","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jpet.2025.103402_bib37","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1055\/s-0038-1650628","article-title":"Results of a screening for von Willebrand disease type 2N in patients with suspected haemophilia A or von Willebrand disease type 1","volume":"76","author":"Schneppenheim","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jpet.2025.103402_bib38","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1160\/TH04-02-0084","article-title":"Recombinant expression of mutations causing von Willebrand disease type Normandy: characterization of a combined defect of factor VIII binding and multimerization","volume":"92","author":"Schneppenheim","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jpet.2025.103402_bib39","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/jth.15247","article-title":"Von Willebrand disease type 2N: an update","volume":"19","author":"Seidizadeh","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jpet.2025.103402_bib40","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1182\/blood-2007-08-109918","article-title":"The tertiary structure and domain organization of coagulation factor VIII","volume":"111","author":"Shen","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jpet.2025.103402_bib41","article-title":"Molecular mechanisms of inhibitor development in hemophilia","volume":"12","author":"Tieu","year":"2020","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.jpet.2025.103402_bib42","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1182\/blood-2007-08-108068","article-title":"Identification of 31 novel mutations in the F8 gene in Spanish hemophilia A patients: structural analysis of 20 missense mutations suggests new intermolecular binding sites","volume":"111","author":"Vencesla","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jpet.2025.103402_bib43","doi-asserted-by":"crossref","first-page":"7235","DOI":"10.3390\/ijms23137235","article-title":"Utilization of AlphaFold2 to predict MFS protein conformations after selective mutation","volume":"23","author":"Xiao","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jpet.2025.103402_bib44","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41392-023-01381-z","article-title":"AlphaFold2 and its applications in the fields of biology and medicine","volume":"8","author":"Yang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jpet.2025.103402_bib45","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1182\/blood-2015-04-641696","article-title":"Visualization of an N-terminal fragment of von Willebrand factor in complex with factor VIII","volume":"126","author":"Yee","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jpet.2025.103402_bib46","doi-asserted-by":"crossref","first-page":"4497","DOI":"10.1016\/j.csbj.2023.09.022","article-title":"Family-wide analysis of integrin structures predicted by AlphaFold2","volume":"21","author":"Zhang","year":"2023","journal-title":"Comput Struct Biotechnol J"},{"key":"10.1016\/j.jpet.2025.103402_bib47","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1182\/blood.V92.1.136.413k35_136_142","article-title":"Some human inhibitor antibodies interfere with factor VIII binding to factor IX","volume":"92","author":"Zhong","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jpet.2025.103402_bib48","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1182\/blood-2012-01-405134","article-title":"Sequence and structure relationships within von Willebrand factor","volume":"120","author":"Zhou","year":"2012","journal-title":"Blood"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525396151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525396151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T01:04:59Z","timestamp":1745975099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356525396151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0022356525396151"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103402","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting the effects of single pathological mutations in hemophilia A and type 2N von Willebrand diseases using AlphaFold2-multimer and AlphaFold3","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103402","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103402"}}